 you know, engineering improvements in the drug to try to address this side effect or reduce it. But those are the three drugs that are mostly used, so there isn't a lot of wiggle room. When I tell you that, you know, in the first year post-transplant, probably 70% of people get those drugs. In a few cases, you may drop one drug or you may add another, but most people get the same drugs. And tell us the primary goal. Okay.